Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Drescher

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
AJNR. American Journal of Neuroradiology|April 10, 2007
Diffusion tensor imaging-based fractional anisotropy quantification in the corticospinal tract of patients with amyotrophic lateral sclerosis using a probabilistic mixture modelS K Schimrigk, B Bellenberg, M Schlüter, et al.
Pediatric Blood & Cancer|November 29, 2023
Outcomes following proton therapy for pediatric esthesioneuroblastomaNicolette R Drescher, Daniel J Indelicato, Roi Dagan, et al.
Journal of Orthopaedic Translation|April 21, 2020
Guidelines for clinical diagnosis and treatment of osteonecrosis of the femoral head in adults (2019 version)Dewei Zhao, Feng Zhang, Benjie Wang, et al.
The Journal of Arthroplasty|May 28, 2025
Osteonecrosis: A More Appropriate Term than Avascular Necrosis-Pathophysiologic RationaleEdward Y Cheng, Alireza Mirzaei, Nobuhiko Sugano, et al.
Nature Medicine|December 15, 2010
Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14Hongjie Wang, Zong-Yi Li, Ying Liu, et al.
Journal of Thrombosis and Haemostasis : JTH|March 27, 2024
Extending venous thromboembolism secondary prevention with apixaban in cancer patients. The EVE trialRobert D McBane, Charles L Loprinzi, Tyler Zemla, et al.
Journal of Thrombosis and Haemostasis : JTH|December 21, 2024
Corrigendum to 'Extending Venous Thromboembolism Secondary Prevention with Apixaban in Cancer Patients. The EVE Trial': [Journal of Thrombosis and Haemostasis Volume 22, Issue 6, June 2024, Pages 1704-1714]Robert D McBane, Charles L Loprinzi, Tyler Zemla, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
AJNR. American Journal of Neuroradiology|April 10, 2007
Diffusion tensor imaging-based fractional anisotropy quantification in the corticospinal tract of patients with amyotrophic lateral sclerosis using a probabilistic mixture modelS K Schimrigk, B Bellenberg, M Schlüter, et al.
Pediatric Blood & Cancer|November 29, 2023
Outcomes following proton therapy for pediatric esthesioneuroblastomaNicolette R Drescher, Daniel J Indelicato, Roi Dagan, et al.
Journal of Orthopaedic Translation|April 21, 2020
Guidelines for clinical diagnosis and treatment of osteonecrosis of the femoral head in adults (2019 version)Dewei Zhao, Feng Zhang, Benjie Wang, et al.
The Journal of Arthroplasty|May 28, 2025
Osteonecrosis: A More Appropriate Term than Avascular Necrosis-Pathophysiologic RationaleEdward Y Cheng, Alireza Mirzaei, Nobuhiko Sugano, et al.
Nature Medicine|December 15, 2010
Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14Hongjie Wang, Zong-Yi Li, Ying Liu, et al.
Journal of Thrombosis and Haemostasis : JTH|March 27, 2024
Extending venous thromboembolism secondary prevention with apixaban in cancer patients. The EVE trialRobert D McBane, Charles L Loprinzi, Tyler Zemla, et al.
Journal of Thrombosis and Haemostasis : JTH|December 21, 2024
Corrigendum to 'Extending Venous Thromboembolism Secondary Prevention with Apixaban in Cancer Patients. The EVE Trial': [Journal of Thrombosis and Haemostasis Volume 22, Issue 6, June 2024, Pages 1704-1714]Robert D McBane, Charles L Loprinzi, Tyler Zemla, et al.
Pageof 4